Mtbvac is being developed for two purposes; firstly, as a more effective and potentially longer-lasting vaccine than BCG ( Bacillus Calmette Guérin) for newborns and secondly, for the prevention of TB in adults and adolescents, for whom there is currently no effective vaccine.
Ocugen said Bharat Biotech completed and posted its phase 3 clinical trial results for Covaxin demonstrating 77.8 per cent efficacy against overall Covid-19 disease
Several research activities are being carried out to study Variants of Concern and assess their suitability for follow-up booster doses, the company said here on Tuesday.
Joel Reifman, Consul General, US Consulate General, Hyderabad said Telangana too has played a very significant role in the Indian healthcare sector by giving the nation the first indigenously developed vaccine by Bharat Biotech.
Innovators with specialised expertise in product development, and large-scale manufacturing, should be allowed to maintain a differential pricing strategy for governments and private hospitals, says the Covaxin maker
The Hyderabad-based firm has started supplying its COVID-19 treatment vaccine to the states based on the allocations received by the central government.